Welcome to LookChem.com Sign In|Join Free

CAS

  • or
(6R,7S)-2-BOC-2-AZA-BICYCLO[2.2.1]HEPT-5-EN-3-ONE, also known as (1R,4S)-3-Oxo-2-azabicyclo[2.2.1]hept-5-ene-2-carboxylic acid 1,1-Dimethylethyl Ester, is an organic compound with a unique bicyclic structure. It is an intermediate in the synthesis of ent-Abacavir (Abacavir EP Impurity A), which is an enantiomer of Abacavir. (6R,7S)-2-BOC-2-AZA-BICYCLO[2.2.1]HEPT-5-EN-3-ONE plays a crucial role in the pharmaceutical industry due to its involvement in the production of anti-HIV drugs.

151792-53-9

Post Buying Request

151792-53-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • (1R,4S)-TERT-BUTYL 3-OXO-2-AZABICYCLO[2.2.1]HEPT-5-ENE-2-CARBOXYLATE

    Cas No: 151792-53-9

  • USD $ 1.9-2.9 / Gram

  • 100 Gram

  • 1000 Metric Ton/Month

  • Chemlyte Solutions
  • Contact Supplier

151792-53-9 Usage

Uses

Used in Pharmaceutical Industry:
(6R,7S)-2-BOC-2-AZA-BICYCLO[2.2.1]HEPT-5-EN-3-ONE is used as an intermediate in the synthesis of ent-Abacavir (Abacavir EP Impurity A) for the production of Abacavir (A105000), an anti-HIV drug. Abacavir is a carbocyclic 2''-deoxyguanosine nucleoside reverse transcriptase inhibitor that is used to treat HIV infection. It works by being converted into its active form, carbovir-triphosphate (CBV-TP), by intracellular enzymes, which then selectively inhibits HIV reverse transcriptase by incorporating into viral DNA.
In the synthesis process, (6R,7S)-2-BOC-2-AZA-BICYCLO[2.2.1]HEPT-5-EN-3-ONE serves as a key building block, contributing to the development of effective anti-HIV medications. The compound's unique structure and properties make it an essential component in the production of Abacavir, which is metabolized in the liver by uridine diphosphate glucuronyltransferase and alcohol dehydrogenase, resulting in inactive glucuronide and carboxylate metabolites.
Overall, (6R,7S)-2-BOC-2-AZA-BICYCLO[2.2.1]HEPT-5-EN-3-ONE is a vital compound in the pharmaceutical industry, particularly in the development and production of anti-HIV drugs. Its role as an intermediate in the synthesis of ent-Abacavir highlights its importance in the fight against HIV and AIDS, contributing to the development of life-saving medications for patients worldwide.

Check Digit Verification of cas no

The CAS Registry Mumber 151792-53-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,1,7,9 and 2 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 151792-53:
(8*1)+(7*5)+(6*1)+(5*7)+(4*9)+(3*2)+(2*5)+(1*3)=139
139 % 10 = 9
So 151792-53-9 is a valid CAS Registry Number.

151792-53-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name tert-butyl (1S,4R)-2-oxo-3-azabicyclo[2.2.1]hept-5-ene-3-carboxylate

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:151792-53-9 SDS

151792-53-9Relevant articles and documents

Synthesis of enantiopure 3,5-disubstituted pyrrolidines by ring-opening/cross-metathesis reaction of 2-azanorbornene derivatives

Arjona, Odon,Cabas, Ma Jose,Nieto-Rubio, Jose,Querejeta, Ana

, p. 2079 - 2086 (2006)

A concise method for the synthesis of enantiopure 3,5-disubstituted pyrrolidines from 2-azanorbornene derivatives is described. The method is also applied to the synthesis of 3,5-disubstituted prolines.

Squarate-based carbocyclic nucleosides: Syntheses, computational analyses and anticancer/antiviral evaluation

Lu, Meijun,Lu, Qing-Bin,Honek, John F.

, p. 282 - 287 (2017)

Squaric acid and its derivatives are versatile synthons and have demonstrated applications in medicinal chemistry, notably as non-classical bioisosteric replacements for functional groups such as carboxylic acids, alpha-amino acids, urea, guanidine, peptide bonds and phosphate/pyrophosphate linkages. Surprisingly, no reports have appeared concerning its possible application as a nucleobase substitute in nucleosides. A preliminary investigation of such an application is reported herein. 3-Amino-4-((1R,4S)-4-(hydroxymethyl)cyclopent-2-en-1-yl)amino-cyclobut-3-ene-1,2-dione, 3-((1R,4S)-4-(hydroxymethyl)cyclopent-2-en-1-yl)amino-4-methoxycyclobut-3-ene-1,2-dione, and 3-hydroxy-4-((1R,4S)-4-(hydroxymethyl)cyclopent-2-en-1-yl)amino-cyclobut-3-ene-1,2-dione sodium salt were synthesized. Computational analyses of their structures and preliminary antitumor and antiviral screening results are reported.

COMPOUNDS TARGETING PRMT5

-

Paragraph 0217, (2021/10/11)

Provided herein are compounds of Formula (I), or pharmaceutically acceptable salts thereof, pharmaceutical compositions that include a compound described herein (including pharmaceutically acceptable salts of a compound described herein) and methods of synthesizing the same. Also provided herein are methods of treating diseases and/or conditions with a compound of Formula (I), or a pharmaceutically acceptable salt thereof.

Synthesis and evaluation of cyclopentane-based muraymycin analogs targeting MraY

Kwak, Seung-Hwa,Lim, Won Young,Hao, Aili,Mashalidis, Ellene H.,Kwon, Do-Yeon,Jeong, Pyeonghwa,Kim, Mi Jung,Lee, Seok-Yong,Hong, Jiyong

, (2021/02/21)

Antibiotic resistance is one of the most challenging global health issues and presents an urgent need for the development of new antibiotics. In this regard, phospho-MurNAc-pentapeptide translocase (MraY), an essential enzyme in the early stages of peptid

COMPOUNDS TARGETING PRMT5

-

Paragraph 0216, (2020/10/20)

Provided herein are compounds of Formula (I), or pharmaceutically acceptable salts thereof, pharmaceutical compositions that include a compound described herein (including pharmaceutically acceptable salts of a compound described herein) and methods of synthesizing the same. Also provided herein are methods of treating diseases and/or conditions with a compound of Formula (I), or a pharmaceutically acceptable salt thereof.

PRMT5 INHIBITORS

-

Page/Page column 66-67, (2020/03/02)

The present invention provides a compound of Formula (I) and the pharmaceutically acceptable salts, esters, and prodrugs thereof, which are PRMT5 inhibitors. Also provided are methods of making compounds of Formula I, pharmaceutical compositions comprising compounds of Formula I, and methods of using these compounds to treat cancer, sickle cell, and hereditary persistence of foetal hemoglobin (HPFH) mutations.

Efficient and stereoselective synthesis of 2′-fluoro-6′-methylene-carbocyclic adenosine (FMCA)

-

, (2016/06/01)

The invention provides a new convergent approach for the synthesis of 2′-fluoro-6′-methylene-carbocyclic adenosine (FMCA) from a readily available starting material (Vince lactam) in fourteen steps. An efficient and practical methodology for stereospecifi

An expedient synthesis of oxazepino and oxazocino quinazolines

Hensbergen, Albertus Wijnand,Mills, Vanessa R.,Collins, Ian,Jones, Alan M.

, p. 6478 - 6483 (2015/11/16)

A synthetic route to a new class of privileged tri- and tetra-cyclic quinazolines containing a medium-sized ring is reported. An expedient synthetic route involving nucleophilic aromatic substitution, and sequential Niementowski and BOP-mediated ring clos

Stereoselective synthesis of 2′-fluoro-6′-methylene carbocyclic adenosine via Vince lactam

Singh, Uma S.,Mishra, Ram C.,Shankar, Ravi,Chu, Chung K.

, p. 3917 - 3923 (2014/05/20)

2′-Fluoro-6′-methylene carbocyclic adenosine (FMCA) is a potent and selective inhibitor of wild type as well as drug-resistant hepatitis B virus (HBV) mutants. FMCA demonstrated excellent anti-HBV activity against both adefovir-resistant and lamivudine-re

Chemoselective opening of Vince lactam epoxide with nitrogen nucleophiles

Giorgi, Gianluca,Guideri, Luca,Ponticelli, Fabio

experimental part, p. 1463 - 1467 (2011/03/23)

Here is reported the chemoselective opening of the amide bond on a Vince lactam derivative with amines, without the cleavage of the epoxide-moiety, getting five new epoxides. Also reported is the rearrangement of the epoxides into the respective five new

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 151792-53-9